MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1177/09287329261479178

Медицинская библиотека · Technology and health care : official journal of the European Society for Engineering and Medicine · 2026

AI-driven biosensing technology for early disease detection: A comprehensive review.

Rehman Tanzeel Ur, Asif Ansari Khawaja Daim, Kahlid Muhammad Zaeem, Sami Ur Rahman Jawwad, Al-Harbi Mohamed, Almudaimeegh Lama, Mohamed Ahmed Amna, Hamd Zuhal Y, Ali Babar

СтатьяОбзорПеревод в очереди

Аннотация

BackgroundArtificial intelligence (AI) is quickly changing the field of biosensing technologies to the point of early, real-time, and individualized disease detection and overcoming significant drawbacks of traditional biosensors, including noise interference, signal drift, and inability to process non-linear biological data.ObjectiveThis review examines the latest developments in AI-driven biosensing systems and assess their impact on diagnostic performance and clinical relevance.MethodsThis critical review focuses on recently published works (2021-2025) on AI-integrated biosensing platforms, such as optical, electrochemical, wearable, and nanomaterial-based platforms, and machine learning, deep learning, edge AI, multimodal data fusion, and federated learning.

Results

CNNs and LSTMs, Transformers and ensemble learning are advanced AI models with better sensitivity, specificity, automatic extraction of features, and prediction accuracy of critical diseases like cancer, cardiovascular, infectious, neurological, and metabolic diseases. Explainable Artificial Intelligence (XAI), nano-enabled biosensors, digital twins, and the Internet of Medical Things (IoMT) are examples of emerging technologies and ideas that are improving real-time, dependable, customized, and privacy-preserving diagnostic systems.ConclusionThe change to proactive and predictive healthcare is being facilitated by AI-enhanced biosensing. It has a good chance in early diagnosis, better treatment planning as well as the decrease in healthcare expenses. Nevertheless, there are still challenges such as lack of data, generalization of models, regulatory authorization, and moral issues.

Для цитирования: Rehman Tanzeel Ur, Asif Ansari Khawaja Daim, Kahlid Muhammad Zaeem, Sami Ur Rahman Jawwad, Al-Harbi Mohamed, Almudaimeegh Lama, Mohamed Ahmed Amna, Hamd Zuhal Y, Ali Babar. AI-driven biosensing technology for early disease detection: A comprehensive review.. Technology and health care : official journal of the European Society for Engineering and Medicine. 2026. DOI: 10.1177/09287329261479178.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.